Long-term sleep laboratory evaluation of flunitrazepam

Pharmacology
Martin ScharfConstantin R Soldatos

Abstract

A sleep laboratory hypnotic drug evaluation study was conducted in which 2 mg flunitrazepam, a benzodiazepine with a half life of intermediate duration, was administered nightly to 6 insomniac subjects for 4 consecutive weeks. The drug was effective with short-term use. However, tolerance developed for sleep maintenance during the intermediate- and long-term drug administration periods. Following drug withdrawal, a significant worsening of sleep above baseline levels occurred. These data are consistent with our previous findings of rebound insomnia following withdrawal of short- and intermediate-acting benzodiazepines.

References

Jan 1, 1985·Psychopharmacology·D Schneider-Helmert
Jan 1, 1989·Psychopharmacology·S SmirneS R Bareggi
Jan 1, 1983·European Journal of Clinical Pharmacology·A Vela-BuenoA Kales
Jul 1, 1996·Psychopharmacology·L Parrino, M G Terzano
Jul 16, 1982·European Journal of Pharmacology·H C Rosenberg, T H Chiu
Jul 1, 1994·Journal of Pharmaceutical and Biomedical Analysis·F Benhamou-BatutB Bannwarth
Jun 1, 1997·Journal of Clinical Psychopharmacology·J H Woods, G Winger
Jan 1, 1982·European Journal of Clinical Pharmacology·J M MontiL D'Angelo
Feb 2, 2006·Expert Opinion on Pharmacotherapy·Martin Scharf
Jul 1, 1987·Journal of Clinical Pharmacology·A KalesR L Manfredi
Mar 1, 1985·Journal of Clinical Pharmacology·E O BixlerConstantin R Soldatos
Nov 1, 1982·Journal of Clinical Pharmacology·A KalesJ D Kales
Apr 1, 1988·Journal of Clinical Pharmacology·S R BareggiS Smirne
Oct 1, 2005·International Review of Psychiatry·Constantin R Soldatos, Thomas J Paparrigopoulos
Sep 25, 2003·Sleep Medicine Reviews·Shawn D Youngstedt
Jul 20, 2007·Journal of Clinical Pharmacy and Therapeutics·T FukasawaK Otani

Related Concepts

Sleep, Slow-Wave
Anti-Anxiety Effect
Benzodiazepine [EPC]
Hypnotics
Flunitrazepam-ratiopharm
Clinical Trials
Benzodiazepines Assay
Benzodiazepines
Transient Insomnia
Half-Life

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.